Clene Inc. Other Current Assets
Clene Inc. (CLNN) had Other Current Assets of $211.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Other Assets, Current $211.00K.
- 2026-03-31: Other Assets, Current $244.00K.
- 2025-12-31: Other Assets, Current $425.00K; Other Assets, Current as first filed $139.00K.
- 2025-09-30: Other Assets, Current $302.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $211.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $244.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $425.00K 10-Q · filed 2026-08-14 | $139.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $302.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $358.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $346.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $137.00K 10-K · filed 2026-03-17 | |
| 2024-09-30 | $777.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $911.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $832.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $568.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $1.03M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $883.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $962.00K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $581.00K 10-K · filed 2024-03-13 | |
| 2021-12-31 | $404.00K 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |